My Hypothesis that Long Hauler's is a Type III Hyper

New Post Public Reply Private Reply Replies (1) Message Board
MGK_2
638
My Hypothesis that Long Hauler's is a Type III Hyper Sensitivity Reaction & a Possible MOA for LL

I've been thinking about this for some time now.

I really believe that Long Hauler Covid is actually a Type 3 Hyper Sensitivity Reaction.

In Type 3, there are Free Antibodies floating in the blood plasma. They are called Serum Immune Complexes. They are antigen-antibody complexes. For long haulers, the antigen-antibody complex would be the more numerous <covid 19 Spike protein mated with the antibody our body made against the spike protein> OR less in number <covid 19 Spike protein mated with the vaccination antibody given to us in vaccine>.

Type 3 is a rather delayed reaction.

Type 1 is fastest, such as after a bee sting, which could be immediate anaphylaxis or an asthma, angioedema, (usually humoral pre-formed antibodies, IgE, eosinophil mediated, mast cell, histamine),

Type 2 is like Type 3 with antigen-antibody complex, but it is not free floating in the blood. Rather, the complex is attached to the cell, so it is cytotoxic. An example of this hypersensitivity reaction is when your body rejects organs in Graft vs. Host Disease, or Myasthenia Gravis / Pemphigus Vulgaris which are more delayed than immediate.

Type 4, is cell to cell mediated hypersensitivity. The T cells do the killing, not the antibody. Here T Cells and Cytokines, CD4 T lymphocytes secrete interferon gamma which stimulate macrophages to make a granuloma. It is the most delayed and the slowest because it takes a long time to make a granuloma which are found in Tuberculosis, histoplasmosis, coccidiomycosis or Sarcoidosis.

Long Covid is right up this time range. It comes on 2-3 weeks after a person had covid and can last for months to years it seems.

Since the antigen-antibody complex is in the blood, it is circulating through out the body. This complex can end up being deposited in the wall of the blood vessels causing Vasculitis, into the joints, causing immune-complex Arthritis which is what happens in Rheumatoid Arthritis & Lupus, they can get stuck in the kidneys, causing immune-complex mediated Nephritis, in the liver causing Hepatitis (children found with hepatitis following vaccination), in the heart, causing myoCarditis (following covid and following vaccine), etc, etc. All of these are common in Long Covid and even following vaccination.

Type 3 could be a generalized reaction all over the body or it could be a localized reaction. When these antigen-antibody complexes are deposited all over the body, into all the tissues and organs, the Complement Cascade system is activated via IgM antibody 1st and IgG 2nd response, (very good at Complement Activation) and subsequently, the patient gets a shit load of C-complements (proteins) into the blood as well. Complements are proteins made by the liver, leading to the complement cascade which results in the MAC which attacks all foreigners. This Complement System acts like a link or a bridge between the Innate and Adaptive Immunity. Complements are made by the liver to help fight the invader, the antigen-antibody complex. The end result of the Complement Cascade results in an entity called the Membrane Attack Complex, MAC which destroys the antigen-antibody complex. But, in a massive overload situation, they may destroy the tissues as well. Why? Because these complexes are deposited in the tissues of the body.

In a massive overload situation as in long covid (long term), or post vaccination syndrome, (short term), this could result in Hypocomplementemia because all the complements are being consumed being used over and over and over again, to destroy the myriad of antigen-antibody complexes imbedded in the tissues. A real life example of hypocomplementemia is lupus, an auto-immune disease where the body creates MAC, but there are no antigen-antibody complexes, so the body is attacking itself, destroying its own tissues. Many Rheumatological disease like RA have increased complement which leads to joint deformity, kidney disease glomerulonephritis, vascular, endocarditis, myocarditis, vasculitis.

Another idea here is that if the liver is weakened by the huge deposition of antibody-antigen complexes and it is spurred into manufacture of all these complements, but it can not do so because it is itself infected with the antibody-antigen complexes and is therefore unable to develop the building blocks of the MACs via the cascade. That would mean that the only way to get rid of these antibody-antigen complexes is either waiting for them to disintegrate in the tissues or by our Natural Killer Cells.

One test to determine if there is a Complement Deficiency in Long Covid would be the CH50 test. It's a screening test of the Markers which indicate the cascade. If it is low, then order the Early Complement Level. We would expect C4 to be low for it to indicate a Classical Pathway, (auto-immune) pointing to Long Covid or post viral.

There is a complement system regulating protein called Decay Accelerating Factor (DAF) which, on the cell's surface, inhibits both complement 3 convertase and complement 5 convertase; another action is to inhibit Natural Killer Cells, both of which may be how the cells are protected from getting destroyed by the complements. DAF interferes with the escalation of the complement cascade whos final result is the Membrane Attack Complex, (MAC); MAC fails to develop.

I'm guessing here, but I'm considering that Leronlimab may have an effect in upregulation of DAF so the tissues can heal while the antigen-antibody complexes get destroyed by Natural Killer Cells which we already know are suppressed by T regulator cells when Leronlimab is given. So Leronlimab may have a double effect on curbing the onslaught on these antigen-antibody complexes, but may prolong the time it takes to get rid of them.

Leronlimab, being a CCR5 blockade, binds to CCR5 with greatest affinity. Therefore, when it is introduced, it displaces any other cytokine attached to CCR5. This gains control of the Natural Killer Cells. It seems to have a regulating effect. A taming effect, reducing the rampant destruction of everything and anything that it doesn't like.

I suspect Leronlimab achieves this Taming Effect on our Immune Response by Activation of the Tregulatory Cells, the T suppressor cells. By activation of these T helper cells, the Immune Cascade is Tamed, it is quieted, it is quelled leading to less inflammation, less swelling, fewer side effects of the war, fewer symptoms. T regs prevent the attack upon our own cells and develop "Tolerance" of what is "Self" vs. "Non-Self or Foreign" thereby preventing Auto-Immune Disease which in effect a form of this Type III Hypersensitivity Reaction. Does Long Covid = Auto-Immune Disease???

AIDS, Acquired ImmunoDeficiency Syndrome is the attack on CD4+ T-Lymphocytes. That is an attack on T helper cells. T regulatory / T suppressor cells. When you kill these T helper lymphocytes, you kill the Adaptive Immune System. No help. B Lymphocytes are left clueless. Natural Killer cells are clueless. Leronlimab shuts down HIV 1 attack, (not HIV 2), and therefore eradicates AIDS when caused by HIV 1.

I think, although we most definitely can say that Leronlimab is a CCR5 blockade, we should probably say the its Mechanism of Action in the majority of its indications will be a T helper cell regulator. T helper cells help other T cells. It also helps Humoral Immunity by helping the B lymphocytes. T helper cells help T cytotoxic cells kill. They help T regulatory cells control/suppress/regulate the cell mediated attack. (T suppressor cells are now called T regulator cells and they help the immune system do its job, but they can suppress it too, so that the immune system does not kill self.) Leronlimab permits the passive response of the immune system, (memory, production of antibodies), while cutting down on the flank attack, (Tcytotoxic cells, Natural Killer Cells), therefore allows the generalized work of getting to the core of the problem without inducing secondary harm in the process. Therefore, the "real" Mechanism of Action that Leronlimab Helps the T helper cell. CCL5 RANTES is main deceiver of the T helper cell, but Leronlimab displaces CCL5 RANTES from its control of this incredibly important component of Cell-mediated Active Immunity and restores appropriate control of this cellular- immunoregulation necessary to promote recognition of self vs. non self.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Teamsters Strike Hits Amazon's Largest U.S. Warehouse

Updated Category News Views 4

Unrest Brewing in Riverside: Amazon's Labor Showdown September 1, 2026, marks a potentially seismic shift in labor disputes within one of America's corporate titans—Amazon. Picture this: workers slinging on their boots, not for a day of hauling goods in Amazon's largest U.S. warehouse, DJT6, but for a united stand outside its gates. Who's at the helm? The Teamsters...

Continue Reading
Kia Achieves Record August Sales Amidst EV Surge

Updated Category News Views 3

Kia's August Record-Breaking Sales: A Closer Look Well, it looks like Kia America’s rolling in some serious momentum, doesn't it? In August, they shattered the ceiling with 83,793 units sold, a new monthly sales record, edging up 1% year-over-year. They’re clearly sitting pretty, riding on a wave of higher demand for both traditional and electrified models. For those...

Continue Reading
Geek+ Spurs Growth with 35.5% Order Surge and New Model

Updated Category News Views 1

Unexpected Surge in Orders Drives Geek+ It looks like Geek+ isn't just playing around in the robotics sandbox anymore. They're delivering some serious results, reporting a 35.5% increase in new signed orders reaching a whopping RMB2.385 billion for the first half of 2026. That's not chump change, and it injects a healthy dose of optimism into their future performance...

Continue Reading
D-Orbit Banks on GomSpace for 2026 Space Ventures

Updated Category News Views 4

Pioneering Paths in Space Logistics Nobody ever said that conquering the final frontier was going to be easy. But D-Orbit, the trailblazer in space logistics, is inking deals like they're playing a cosmic chess game, and GomSpace is the knight they’re moving across the board. Their latest maneuver? GomSpace gets tasked with powering the D-Orbit's missions through 2027,...

Continue Reading
iRobot's Roomba Max 875: The Ultimate Cleaning Machine

Updated Category News Views 0

Roomba Max 875 Combo: Setting a New Standard Alright, folks, iRobot's at it again—unleashing what they tout as their beefiest cleaner to date, the Roomba Max 875 Combo Robot. It's a name that might twist your tongue, and this technological titan's feature list is equally complex. You know the routine with these fancy gadget launches: big promises, shiny features, but...

Continue Reading
Chiraag Shah Joins Crowell & Moring in Major Move

Updated Category News Views 2

Shah's Strategic Move to Crowell & Moring The legal landscapes sometimes unfold like a strategic chessboard. Chiraag Shah just made a bold move by joining Crowell & Moring's International Dispute Resolution Practice in London. This isn't just a feather in the cap—it's a significant muscle flex in a competitive field where arbitration prowess can make or break...

Continue Reading
Youlife Partners for Vocational Training in Ji'an

Updated Category News Views 4

Big Moves in Education for Youlife Youlife Group Inc., the bigwig in China's blue-collar work scene, just inked a strategic pact that's worth a second look—or several. Teaming up with Ji'an Industry-Education Integration Technology Co., Ltd., they've got a plan to turn heads and maybe some profit margins too. This isn't just about signing papers; it's about forging a...

Continue Reading
Club Med Unveils Major Ski Sale: Up to $1,040 Off

Updated Category News Views 1

Club Med's "Ski Days" Deal: A Closer Look As folks start stashing away those beach towels and gearing up for the colder months, Club Med’s throwing a bone to skiers and snowboarders alike with their "Ski Days" sale. Running for just 15 days, the deal offers up to $1,040 off ski vacations at some pretty iconic spots—the French Alps and Quebec-Charlevoix to be exact. If...

Continue Reading
Shiga and Michigan: 60 Years of Friendship & Innovation

Updated Category News Views 5

Shiga and Michigan: A Tale of Two Lakes The relationship between Shiga Prefecture in Japan and the U.S. state of Michigan isn’t your run-of-the-mill connection. It began in 1968, driven by a shared reverence for their massive lakes—Lake Biwa clasped in Shiga's arms and Michigan's cherished Great Lakes. Building Bridges Beyond Water This isn’t just about lakes...

Continue Reading
Huawei's Gaming Play in Europe: A Strategic Dive

Updated Category News Views 3

Huawei's European Focus: Aligning Games and Growth Straight out of Düsseldorf, Huawei's making a statement at their Games Summit 2026, rallying Chinese game developers to chase the European dream. The timing? Right alongside Gamescom — clever, if you ask me. Huawei's not tip-toeing around; they're slamming down bridges between Asian creativity and European demand,...

Continue Reading

Top 5 Most Recently Viewed Articles

Schroeder MD Regenerative Orthopedics Enhances Patient Care

Updated Category News Views 115

Schroeder MD Regenerative Orthopedics Expands Its Reach Schroeder MD Regenerative Orthopedics (SRO), founded by distinguished orthopedic surgeon Keith E. Schroeder, MD, is thrilled to unveil its second location in a bustling area. This new clinic, conveniently located nearby well-known shopping spots, marks an exciting step in the company's mission to provide enhanced...

Continue Reading
Aker ASA Shares Acquisition Under Employee Program

Updated Category News Views 118

Aker ASA Shares Acquisition Under Employee Program Aker ASA recently took a pivotal step by acquiring 6,526 of its own shares at an average price of NOK 534.53 per share. This transaction reflects the company's ongoing commitment to its employees through its share program. Details of the Share Acquisition The purchase of these shares was made on the Oslo Stock Exchange...

Continue Reading
Exploring Smart Cities and Innovations in Digital Real Estate

Updated Category News Views 106

Understanding the Impact of Digital Technology on Real Estate During the recent summit focused on real estate innovations, key stakeholders gathered to discuss how advancements like Digital Twins, Blockchain, and AI are revolutionizing the industry. This event, held at an iconic venue, featured insightful discussions, encouraging attendees to envision a future where...

Continue Reading
Neumora Therapeutics Faces Challenges Amidst Market Volatility

Updated Category News Views 117

Neumora Therapeutics Stock Struggles Amid Market Pressures Neumora Therapeutics Inc. (NMRA) has experienced significant stock decline, recently hitting a 52-week low of $1.89 as it grapples with a tumultuous market. While the company has managed to maintain a FAIR financial health score, analysts have set ambitious price targets ranging from $15 to $30. This biotechnology...

Continue Reading
Important Gathering to Discuss Future Directions of AS Storebælt

Updated Category News Views 47

Overview of the Extraordinary General Meeting The upcoming extraordinary general meeting is an important event aimed at uniting stakeholders to discuss significant developments related to AS Storebælt. These gatherings play a vital role in ensuring that the company’s direction aligns with shareholder expectations while also addressing any emerging issues. Attendees...

Continue Reading